Krömker Volker, Schmenger Anne, Klocke Doris, Mansion-de Vries Ellen Maria, Wente Nicole, Zhang Yanchao, Leimbach Stefanie
Department of Veterinary and Animal Sciences, Section for Production, Nutrition and Health, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.
Department of Bioprocess Engineering and Microbiology, Faculty II, Hannover University of Applied Sciences and Arts, Hannover, Germany.
Front Vet Sci. 2021 May 20;8:660804. doi: 10.3389/fvets.2021.660804. eCollection 2021.
To reduce ineffective antimicrobial usage in the treatment of non-severe clinical mastitis (CM) in cows with long-lasting udder diseases, non-antibiotic therapy with a non-steroidal anti-inflammatory drug (NSAID) was conducted and evaluated in a non-blinded, positively controlled, non-inferiority trial. Therefore, three-time systemic ketoprofen treatment at intervals of 24 h was evaluated in comparison with the reference treatment of solely antibiotic therapy in a field study on nine free-stall dairy farms located in Northern Germany. Cows with previous CM cases in current lactation and/or with long-lasting high somatic cell counts in preceding dairy herd improvement test days were randomly allocated to one of the two treatment groups in cases of mild to moderate CM. Quarter foremilk samples of the affected quarters were taken for cyto-bacteriological investigation before treatment as well as ~14 and 21 d after termination of therapy. Both treatment groups were compared regarding the bacteriological cure (BC) as the primary outcome. Clinical cure (CC) and no CM relapse within 60 d after the end of treatment (no R60) were chosen as secondary outcomes. The study resulted in the following outcomes: was most frequently identified in microbiological culture from pre-treatment samples, followed by and and other coliforms. No significant differences between the NSAID treatment and the reference treatment were detected regarding CC and CM recurrence (no R60). Although the sole ketoprofen therapy resulted in a numerically lower likelihood of BC, there were no significant differences to the reference treatment. Considering the selection criteria in this study, the results indicate that in mild to moderate CM cases exclusive treatment with ketoprofen may constitute an alternative to antimicrobial intramammary therapy, providing an opportunity for reduction of antibiotic usage. However, non-inferiority evaluations were inconclusive. Further investigations with a larger sample size are required to confirm the results and to make a distinct statement on non-inferiority.
为减少患有持续性乳房疾病的奶牛非严重临床型乳房炎(CM)治疗中抗菌药物的无效使用,在一项非盲法、阳性对照、非劣效性试验中进行并评估了使用非甾体抗炎药(NSAID)的非抗生素治疗。因此,在德国北部9个散栏式奶牛场进行的一项田间研究中,评估了每隔24小时进行三次全身酮洛芬治疗,并与单纯抗生素治疗的对照治疗进行比较。在当前泌乳期有过CM病例和/或在前次奶牛群改良测试日有持续高体细胞计数的奶牛,若患有轻度至中度CM,则被随机分配到两个治疗组之一。在治疗前以及治疗结束后约14天和21天,采集受影响乳房象限的乳前样进行细胞细菌学调查。将两个治疗组在细菌学治愈(BC)方面作为主要结局进行比较。临床治愈(CC)以及治疗结束后60天内无CM复发(无R60)被选为次要结局。该研究得出以下结果: 在治疗前样本的微生物培养中最常被鉴定出,其次是 和 以及其他大肠菌群。在CC和CM复发(无R60)方面,未检测到NSAID治疗与对照治疗之间存在显著差异。尽管单纯酮洛芬治疗导致BC的数值可能性较低,但与对照治疗无显著差异。考虑到本研究中的选择标准,结果表明,在轻度至中度CM病例中,单独使用酮洛芬治疗可能是乳房内抗菌治疗的一种替代方法,为减少抗生素使用提供了机会。然而,非劣效性评估尚无定论。需要进行更大样本量的进一步研究以证实结果并就非劣效性做出明确说明。